FdaApplication
BLA 125031
Identifiers
- fda_app_no: BLA125031
Properties
| Property | Value |
|---|---|
| applicant_name | Amgen Inc. |
| application_type | BLA |
| approval_date | 2002-01-31 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEULASTA | PEGFILGRASTIM | 6MG/0.6ML | Injection |
| NEULASTA ONPRO | — | 6MG/0.6ML | Injection |
2 products